Guggenheim Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.7M | Buy |
20,242
+2,818
| +16% | +$1.58M | 0.07% | 278 |
|
|
2026
Q1 | $9.79M | Sell |
17,424
-3,918
| -18% | -$2.51M | 0.08% | 272 |
|
|
2025
Q4 | $14.4M | Buy |
21,342
+1,402
| +7% | +$955K | 0.1% | 197 |
|
|
2025
Q3 | $12.7M | Sell |
19,940
-1,229
| -6% | -$746K | 0.09% | 221 |
|
|
2025
Q2 | $11.4M | Buy |
21,169
+3,577
| +20% | +$1.71M | 0.09% | 226 |
|
|
2025
Q1 | $7.39M | Sell |
17,592
-5,091
| -22% | -$2.21M | 0.07% | 315 |
|
|
2024
Q4 | $9.38M | Sell |
22,683
-122
| -0.5% | -$53.5K | 0.08% | 264 |
|
|
2024
Q3 | $11.5M | Sell |
22,805
-2,603
| -10% | -$1.26M | 0.08% | 265 |
|
|
2024
Q2 | $12.4M | Sell |
25,408
-4,169
| -14% | -$2.09M | 0.09% | 240 |
|
|
2024
Q1 | $16M | Buy |
29,577
+994
| +3% | +$543K | 0.11% | 178 |
|
|
2023
Q4 | $15.9M | Buy |
28,583
+412
| +1% | +$193K | 0.12% | 177 |
|
|
2023
Q3 | $12.3M | Buy |
28,171
+5,039
| +22% | +$2.51M | 0.11% | 212 |
|
|
2023
Q2 | $11.6M | Buy |
23,132
+2,305
| +11% | +$1.1M | 0.09% | 240 |
|
|
2023
Q1 | $10.4M | Sell |
20,827
-554
| -3% | -$265K | 0.09% | 272 |
|
|
2022
Q4 | $8.72M | Buy |
21,381
+270
| +1% | +$105K | 0.08% | 328 |
|
|
2022
Q3 | $6.88M | Buy |
21,111
+517
| +3% | +$190K | 0.06% | 387 |
|
|
2022
Q2 | $7.22M | Sell |
20,594
-2,759
| -12% | -$1.13M | 0.06% | 406 |
|
|
2022
Q1 | $12.8M | Sell |
23,353
-5,337
| -19% | -$2.81M | 0.08% | 312 |
|
|
2021
Q4 | $18.9M | Sell |
28,690
-282
| -1% | -$177K | 0.1% | 225 |
|
|
2021
Q3 | $18M | Sell |
28,972
-1,126
| -4% | -$757K | 0.11% | 204 |
|
|
2021
Q2 | $19M | Buy |
30,098
+3,943
| +15% | +$2.18M | 0.11% | 202 |
|
|
2021
Q1 | $12.8M | Sell |
26,155
-3,422
| -12% | -$1.71M | 0.08% | 286 |
|
|
2020
Q4 | $14.8M | Buy |
29,577
+4,352
| +17% | +$1.95M | 0.09% | 218 |
|
|
2020
Q3 | $9.92M | Sell |
25,225
-2,753
| -10% | -$1.02M | 0.07% | 283 |
|
|
2020
Q2 | $9.24M | Buy |
27,978
+6,079
| +28% | +$1.76M | 0.07% | 290 |
|
|
2020
Q1 | $5.3M | Sell |
21,899
-6,901
| -24% | -$1.8M | 0.05% | 418 |
|
|
2019
Q4 | $7.52M | Sell |
28,800
-6,548
| -19% | -$1.73M | 0.06% | 429 |
|
|
2019
Q3 | $9.61M | Buy |
35,348
+10,020
| +40% | +$2.79M | 0.08% | 327 |
|
|
2019
Q2 | $6.97M | Sell |
25,328
-1,785
| -7% | -$440K | 0.06% | 434 |
|
|
2019
Q1 | $6.06M | Sell |
27,113
-8,869
| -25% | -$1.83M | 0.05% | 514 |
|
|
2018
Q4 | $6.69M | Sell |
35,982
-14,776
| -29% | -$3.03M | 0.06% | 420 |
|
|
2018
Q3 | $12.7M | Buy |
50,758
+14,907
| +42% | +$3.62M | 0.08% | 269 |
|
|
2018
Q2 | $7.81M | Sell |
35,851
-312,188
| -90% | -$64.3M | 0.05% | 447 |
|
|
2018
Q1 | $66.6M | Sell |
348,039
-55,865
| -14% | -$10.3M | 0.16% | 159 |
|
|
2017
Q4 | $63.2M | Sell |
403,904
-109,396
| -21% | -$17.2M | 0.15% | 198 |
|
|
2017
Q3 | $79.8M | Sell |
513,300
-4,423
| -0.9% | -$699K | 0.19% | 76 |
|
|
2017
Q2 | $83.6M | Sell |
517,723
-14,444
| -3% | -$2.35M | 0.22% | 60 |
|
|
2017
Q1 | $82.3M | Buy |
532,167
+413,933
| +350% | +$57.1M | 0.22% | 54 |
|
|
2016
Q4 | $13.9M | Buy |
118,234
+98,136
| +488% | +$11.2M | 0.04% | 575 |
|
|
2016
Q3 | $2.27M | Sell |
20,098
-2,199
| -10% | -$232K | 0.01% | 1543 |
|
|
2016
Q2 | $2.07M | Buy |
22,297
+1,085
| +5% | +$93.2K | 0.01% | 1544 |
|
|
2016
Q1 | $1.66M | Sell |
21,212
-16,118
| -43% | -$1.16M | 0.01% | 1695 |
|
|
2015
Q4 | $2.72M | Sell |
37,330
-133,755
| -78% | -$9.54M | 0.01% | 1392 |
|
|
2015
Q3 | $12.7M | Sell |
171,085
-2,379
| -1% | -$170K | 0.04% | 665 |
|
|
2015
Q2 | $11.1M | Sell |
173,464
-15,634
| -8% | -$1.08M | 0.03% | 790 |
|
|
2015
Q1 | $14.6M | Sell |
189,098
-13,076
| -6% | -$1.02M | 0.03% | 716 |
|
|
2014
Q4 | $15M | Buy |
202,174
+154,010
| +320% | +$10.8M | 0.04% | 703 |
|
|
2014
Q3 | $2.84M | Buy |
48,164
+8,358
| +21% | +$528K | 0.01% | 1516 |
|
|
2014
Q2 | $2.66M | Sell |
39,806
-16,902
| -30% | -$1.07M | 0.01% | 1575 |
|
|
2014
Q1 | $3.44M | Buy |
56,708
+39,272
| +225% | +$2.34M | 0.01% | 1371 |
|
|
2013
Q4 | $927K | Sell |
17,436
-5,604
| -24% | -$295K | ﹤0.01% | 2279 |
|
|
2013
Q3 | $1.15M | Buy |
23,040
+16,748
| +266% | +$805K | ﹤0.01% | 2017 |
|
|
2013
Q2 | $283K | Buy |
+6,292
| New | +$275K | ﹤0.01% | 2636 |
|
Other funds holding IDXX
Guggenheim Capital's IDXX Position: Q2 2026 in Review
Guggenheim Capital increased its Idexx Laboratories (IDXX) stake by 16% in Q2 2026, buying an estimated $1.58M and bringing the position to 20,242 shares worth $10.7M. The position accounts for 0.07% of the portfolio, ranked #278.
Guggenheim Capital first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $83.6M in Q2 2017. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Guggenheim Capital held 20,242 shares of Idexx Laboratories worth $10.7M as of Q2 2026.
- Guggenheim Capital bought 2,818 Idexx Laboratories shares in Q2 2026, an estimated $1.58M.
- Idexx Laboratories made up 0.07% of Guggenheim Capital's portfolio in Q2 2026, its #278 holding.
- Guggenheim Capital first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
- Guggenheim Capital's Idexx Laboratories position peaked at $83.6M in Q2 2017.
- 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.